S100A8 and cardiac hypertrophy: The present findings expand the knowledge of how S100A8/A9 in myeloid cells contributes to the TAC-induced transition from cardiac hypertrophy to HF and reveal that S100A8/A9 plays a critical role in the pathogenesis of HF.